BETHESDA, Md., April 1, 2019 /PRNewswire/ -- Anthony "Tony" Gregg, MD, MBA, FACOG, FACMG, of Dallas, Texas, is the new president of the American College of Medical Genetics and Genomics (ACMG), the national professional organization for clinical and laboratory genetics professionals.
Dr. Gregg assumes the responsibility from Louanne Hudgins, MD, FACMG, of Palo Alto, Calif., who completed her two-year term at the 2019 Annual Clinical Genetics Meeting in Seattle, Wash., this April.
"It's an honor for me to hold this position at a time when genetics and genomics has potential for such widespread impact on medicine and society," said Dr. Gregg. "There's a lot of responsibility that comes with this position, so I don't take it lightly. I'm ready to roll up my sleeves and engage."
"We look forward to Dr. Gregg's leadership during this time of rapid advancement, both for the College and within the field of genetics and genomics," said Michael S. Watson, PhD, FACMG, executive director of the ACMG. "His experience as a member of ACMG's Board of Directors combined with his history of leadership and participation with other groups—including a focus on the rapidly evolving area of prenatal genetic and genomic testing and screening—will be a tremendous asset as we forge productive partnerships for the future."
During his previous two years as president elect, Dr. Gregg served on several committees of the ACMG Board of Directors and ACMG Foundation Board, participated on several practice guideline work groups, and served as liaison between ACMG and the American College of Obstetricians and Gynecologists, a post he has held since 2013. He was also invited before Congress in 2017 to give expert briefing on advances in prenatal genetic screening on behalf of ACMG. His earlier involvement with ACMG includes serving on the Board of Directors from 2009–2015, as Clinical Vice President from 2013–2015, and as a member of the Practice Guidelines Committee from 2013–2015.
"Working with members of ACMG has allowed me to collaborate with some of the brightest people in medicine, and it has been an absolute privilege," Dr. Gregg noted. "It's really opened my eyes to the broad responsibilities of the College."
Dr. Gregg is a member of numerous national and international professional societies, including the American College of Obstetricians and Gynecologists, the Society for Maternal-Fetal Medicine, the Society for Reproductive Investigation, the International Society of Prenatal Diagnosis, and the Perinatal Research Society, where he served as secretary-treasurer of from 2004–2009 and president from 2016–2017.
Recognized as one of the Best Doctors in America for 2017–2018, Dr. Gregg currently holds positions as Chair of the Department of Obstetrics and Gynecology and Chief of Maternal Fetal Medicine at Baylor University Medical Center. Previously at the University of Florida College of Medicine, where he was recognized for exemplary teaching, Dr. Gregg was Director of Maternal Fetal Medicine and the Maternal-Fetal Medicine Fellowship Program from 2011–2017 as well as the Director of Obstetrics at Shands Hospital.
Dr. Gregg's principal research interests relate to high-risk obstetrics. He participated as an investigator on numerous clinical trials and was supported by the National Institutes of Health to evaluate a mouse model of hypertension in pregnancy during his time as an associate professor at the University of South Carolina School of Medicine, from 2004–2011. He has also served as a reviewer on multiple special emphasis panels for the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), including five years as chair of the advisory board for the institute's Genomics and Proteomics Network for Preterm Birth Research.
Dr. Gregg studied biology as an undergraduate at Loyola University of Chicago and earned his medical degree at Loyola University Stritch School of Medicine. He completed his residency in obstetrics and gynecology at Loyola University Foster McGaw Hospital, his fellowship in maternal-fetal medicine at the University of Iowa Hospitals and Clinics, and his postdoctoral fellowship in medical genetics at Baylor College of Medicine.
About the ACMG and ACMG Foundation
Founded in 1991, the American College of Medical Genetics and Genomics (www.acmg.net) advances the practice of medical genetics and genomics by providing education, resources and a voice for nearly 2200 biochemical, clinical, cytogenetic, medical and molecular geneticists, genetic counselors and other healthcare professionals, nearly 80% of whom are board certified in the medical genetics specialties. ACMG is the only nationally recognized medical organization dedicated to improving health through the practice of medical genetics and genomics. The College's mission includes the following goals: 1) to define and promote excellence in the practice of medical genetics and genomics and to facilitate the integration of new research discoveries into medical practice; 2) to provide medical genetics and genomics education to fellow professionals, other healthcare providers, and the public; 3) to improve access to medical genetics and genomics services and to promote their integration into all of medicine; and 4) to serve as advocates for providers of medical genetics and genomics services and their patients. Genetics in Medicine, published monthly, is the official ACMG peer-reviewed journal. ACMG's website (www.acmg.net) offers a variety of resources including Policy Statements, Practice Guidelines, Educational Resources, and a Find a Geneticist tool. The educational and public health programs of the American College of Medical Genetics are dependent upon charitable gifts from corporations, foundations, and individuals through the ACMG Foundation for Genetic and Genomic Medicine (www.acmgfoundation.org).
Kathy Moran, MBA
SOURCE American College of Medical Genetics and Genomics